Serum institute submits data from trials of vaccine

NEW DELHI: Pune-based Serum Institute of India (SII) has submitted additional updated

data

from clinical trials of Covishield sought by the drug regulator’s panel evaluating

Covid vaccine applications

for emergency use authorisation, official sources said, reports

Sushmi Dey

.

The Subject Expert Committee (SEC) on Covid vaccine under the Drugs Controller General of India had asked

Bharat Biotech

and SII to produce updated data from ongoing clinical trials in India.

The latest development may once again set the clock ticking for the launch of the vaccine, as the government is expecting to roll out vaccination against Covid-19 by mid-January.

Stay updated with the latest news on Times of India. Don't miss daily games like Crossword, Sudoku, and Mini Crossword.